Showing 1 - 2 results of 2 for search 'Chan-Young Ock', query time: 0.01s Refine Results
  1. 1
    Changes in the tumor microenvironment in recurrent head and neck squamous cell carcinoma and its implication on efficacy of immune checkpoint inhibitors

    Changes in the tumor microenvironment in recurrent head and neck squamous cell carcinoma and its implication on efficacy of immune checkpoint inhibitors by Dong Hyun Kim, Mingu Kang, Gahee Park, Mohammad Mostafavi, Yoojoo Lim, Chan-Young Ock, Jiwon Koh, Yoon Kyung Jeon, Kyeong Cheon Jung, Soon-Hyun Ahn, Eun-Jae Chung, Seong-Keun Kwon, Bhumsuk Keam

    Published 2024-11-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    First‐In‐Human Dose Finding Study of Venadaparib (IDX‐1197), a Potent and Selective PARP Inhibitor, in Patients With Advanced Solid Tumors

    First‐In‐Human Dose Finding Study of Venadaparib (IDX‐1197), a Potent and Selective PARP Inhibitor, in Patients With Advanced Solid Tumors by Sung‐Bae Kim, Kyun‐Seop Bae, Jae Lyun Lee, Won Sik Lee, Chan‐Young Ock, Myong‐Jae Lee, Jeongsook Bang, Min Ju Hong, Eun‐Jihn Roh, Kyoung Soo Ha, Jong‐Ha Lim, Yong‐Man Kim

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: